Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hydrating Cream is a topical emollient formulation developed by Chang Gung Memorial Hospital, specifically designed to address and prevent repeated skin injuries in high-intensity athletes. It is currently being evaluated in clinical trials for its ability to improve hand skin integrity in tug-of-war players, who frequently experience abrasions, skin avulsions, and friction-related damage. The cream serves as a non-steroidal alternative for skin barrier restoration, aiming to reduce the risk of bacterial infections and long-term skin degradation associated with chronic mechanical stress. Beyond athletic injuries, it is also indicated for the management of eczematous skin diseases where maintaining skin hydration and barrier function is critical for therapeutic success.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hydrating Cream.